Wang Wei-Qian, Gao Xue, Huang Sha-Sha, Kang Dong-Yang, Xu Jin-Cao, Yang Kun, Han Ming-Yu, Zhang Xin, Yang Su-Yan, Yuan Yong-Yi, Dai Pu
Beijing Key Lab of Hearing Impairment Prevention and Treatment, ChinaNational Clinical Research Center for Otolaryngologic DiseasesState Key Lab of Hearing Science, Chinese PLA General Hospital, Chinese PLA Medical School, Ministry of Education, College of Otolaryngology Head and Neck Surgery, Beijing, China.
Department of Otolaryngology, PLA Rocket Force Characteristic Medical Center, Beijing, China.
Front Genet. 2022 May 27;13:825082. doi: 10.3389/fgene.2022.825082. eCollection 2022.
Non-syndromic hearing loss (NSHL) is a common neurosensory disease with an extreme genetic heterogeneity which has been linked to variants in over 120 genes. The gene (DFNB77), encoding lipoxygenase homology domain 1, is a rare hearing loss gene found in several populations. To evaluate the importance of variants in Chinese patients with NSHL, we performed genetic analysis on in 2,901 sporadic Chinese patients to identify the aspect and frequency of causative variants. Next-generation sequencing using a custom gene panel of HL was conducted on 2,641 unrelated patients and whole-exome sequencing on the remaining 260 patients. A total of 33 likely causative variants were identified in 21 patients, including 20 novel variants and 13 previously reported pathogenic variants. Each of the 20 novel variants was evaluated according to ACMG criteria. These findings showed that causative variants in were found in about 0.72% (21/2,901) of Chinese NSHL patients. This study is by far the largest number of novel variants identified in this gene expanding the range of pathogenic variants in , and suggests that variants in this gene occur relatively commonly in Chinese NSHL patients. This extensive investigation of in Chinese NSHL patients proposed six recurrent variants. These findings may assist in both molecular diagnosis and genetic counseling.
非综合征性听力损失(NSHL)是一种常见的神经感觉疾病,具有高度的遗传异质性,已与120多个基因的变异相关联。编码脂氧合酶同源结构域1的基因(DFNB77)是在多个群体中发现的一种罕见的听力损失基因。为了评估DFNB77基因变异在中国NSHL患者中的重要性,我们对2901例散发的中国患者进行了基因分析,以确定DFNB77致病变异的情况和频率。对2641例无关患者进行了使用定制的听力损失基因panel的二代测序,并对其余260例患者进行了全外显子测序。在21例患者中总共鉴定出33个可能的致病变异,包括20个新变异和13个先前报道的致病变异。根据美国医学遗传学与基因组学学会(ACMG)标准对这20个新变异中的每一个进行了评估。这些发现表明,在中国NSHL患者中约0.72%(21/2901)发现了DFNB77的致病变异。这项研究是迄今为止在该基因中鉴定出的新变异数量最多的研究,扩大了DFNB77致病变异的范围,并表明该基因的变异在中国NSHL患者中相对常见。对中国NSHL患者中DFNB77的广泛研究提出了六个反复出现的DFNB77变异。这些发现可能有助于分子诊断和遗传咨询。